Tumor infiltrating lymphocytes isolated from prostate cancers have significantly higher IL-10 expression than T lymphocytes from peripheral blood, indicating IL-10 can influence cells in the tumor microenvironment and immune response [15]. Here, IL10 is linked to prostate carcinoma.